← Back to patent-cliff list
CAS 1224887-82-4
2-((5-chloro-2-((1-isopropyl-3-methyl-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)benzonitrile
Codes: GSK-2256098-005
Application context (from source-drug indications)
AdenocarcinomaGSK-2256098Pancreatic cancerGSK-2256098MeningiomaGSK-2256098Pulmonary hypertensionGSK-2256098Solid tumourGSK-2256098
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| GSK-2256098 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,5-dichloro-4-iodopyridine→2-aminobenzonitrile→2-((2,5-dichloropyridin-4-yl)amino)benzonitrile→1-isopropyl-3-methyl-1H-pyrazol-5-amine→2-((5-chloro-2-((1-isopropyl-3-methyl-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)benzonitrile→2-((5-chloro-2-((1-isopropyl-3-methyl-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)benzoic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.